Table 2.
Oocyte maturation abnormalities | |||||||||
---|---|---|---|---|---|---|---|---|---|
Patient No. | Age | Type of infertility | BMI (kg/m2) | Basal AFC | AMH (μg/L) | Previous infertility treatment: stimulation protocols | Previous infertility treatment: ovulation trigger | MII oocytes retrieved in ART cycles* | Good-quality embryos |
10 | 31 | Primary | 25.2 | 13 | 6.11 | 1st cycle GnRH antagonist; 2nd cycle long GnRH agonist | 10,000 IU hCG trigger (2 cycles) | Yes | Yes |
11 | 31 | Primary | 21.4 | 13 | 1.72 | 3 GnRH antagonist cycles; 1 long GnRH agonist cycle | 10,000 IU hCG trigger (4 cycles) | No | No |
12 | 26 | Primary | 24.0 | 6 | 0.99 | 2 GnRH antagonist cycles; 1 long GnRH agonist cycle | 10,000 IU hCG trigger (3 cycles) | Yes | No |
13 | 34 | Primary | 26.4 | 28 | 3.33 | 13 cycles (GnRH antagonist and long GnRH agonist) | 10,000 IU hCG trigger (13 cycles) | Yes | Yes |
14 | 33 | Primary | 21.0 | 8 | 1.10 | 2 cycles (no details available) | No details available | No | No |
15 | 28 | Primary | 22.0 | 12 | 2.79 | 3 long GnRH agonist cycles | 10,000–15,000 hCG trigger | Yes | No |
16 | 26 | Primary | 32.2 | 24 | 3.02 | 3 cycles (no details available); 4th cycle GnRH antagonist | hCG trigger (3 cycles); 4th cycle 10,000 IU hCG + 0.3 mg triptorelin | Yes | Yes |
17 | 35 | Primary | 23.2 | 15 | 5.13 | 2 cycles (no details available); 3rd cycle GnRH antagonist; 4th cycle long GnRH agonist | No details available (2 cycles); 3rd cycle 0.2 mg triptorelin; 4th cycle 10,000 IU hCG | Yes | No |
18 | 36 | Primary | 25.6 | 15 | 3.26 | 3 GnRH long agonist cycles | 10,000–20,000 IU hCG | Yes | No |
19 | 33 | Primary | 23.7 | 18 | 1.87 | 2 GnRH antagonist cycles; 1 long GnRH agonist cycle | 10,000 IU hCG | No | No |
20 | 32 | Primary | 23.0 | 13 | 3.26 | 4 cycles (short and long GnRH agonist) | hCG trigger | No | No |
21 | 33 | Primary | 22.0 | 24 | 3.73 | 3 cycles (no details available) | hCG trigger | Yes | No |
22 | 31 | Primary | 20.3 | 40 | 4.6 | 3 cycles (no details available) | No details available | No | No |
23 | 24 | Primary | 22 | 45 | 7.45 | 4 cycles (no details available) | No details available | No | No |
24 | 21 | Primary | 22.8 | 11 | 3.81 | 3 GnRH long agonist cycles | hCG trigger | No | No |
25 | 31 | Primary | 19.2 | 13 | U | 1 GnRH antagonist cycle; 1 long GnRH agonist cycle | 10,000 IU hCG trigger | Yes | No |
26 | 31 | Primary | 24.1 | 29 | 8.12 | 1 GnRH short agonist cycles | 10,000 IU hCG trigger | No | No |
27 | 36 | Primary | 21.7 | 20 | 1.5 | several cycles, different protocols | hCG trigger | No | No |
28 | 25 | Primary | 24.3 | 14 | 3.5 | 5 cycles, different protocols | hCG trigger | Yes | Yes |
AFC, antral follicle count; AMH, anti-Müllerian hormone; ART, assisted reproductive technologies; ICSI, intracytoplasmic sperm injection; IVF, in vitro fertilization; MII, mature oocytes